CR

Critical Reviews in Oncology/Hematology

Critical Reviews in Oncology/Hematology is the official journal of the European School of Oncology and the International Society of Liquid Biopsy. It publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world, covering themes including basic experimental oncology, clinical research, hematology, immunotherapy, molecular pathology, genomics and omics, liquid biopsy, pediatric oncology, radiotherapy, surgery, palliative support, and health policy.

Looking to publish in Critical Reviews in Oncology/Hematology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Hematology, Oncology
Impact Factor 5.6
Quartile Q1
Open Access Type Hybrid
ISSN 1040-8428
eISSN 1879-0461
Invitation Only No
Cost Range Open Access APC: USD 4,180 (excluding taxes); subscription: no publication fee charged to authors.

Submission Instructions

Critical Reviews in Oncology/Hematology accepts the following article types. Click on an article type to view submission instructions.

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must not exceed 250 words. Abstract must be unstructured.
Manuscript Manuscript should not exceed 8,000 words excluding tables and figures. Manuscript must be divided into clearly defined numbered sections and include a Critical View section at the end of the review. Submission must include 1 to 7 English keywords, 3 to 5 article highlights submitted separately, and any AI or AI-assisted tool use in the research design or methods must be disclosed reproducibly in the methods section.
References A maximum of 100 references is recommended, with exceptions possible subject to editor approval. Reference list must be arranged alphabetically and then chronologically if necessary, with same-year works by the same author distinguished by letters.
Figures & Tables Review Articles should not exceed 6 figures and/or tables. Tables must be placed next to the relevant text or on separate pages at the end of the article, and figures must be supplied as separate files. Tables must be editable text with captions and figures must each have a caption.
Reformat to Critical Reviews in Oncology/Hematology using Livewrite Premium

Recent Publications

Paraneoplastic glomerulopathy associated with solid tumors: A review

Mengsi Hu, Qiqi Ma, Liguang Wang, Zhimei Lv, Rong Wang

10.1016/j.critrevonc.2026.105550
View Publication

Survival by Design: Cell Fate Dynamics in Classical Hodgkin Lymphoma

Matei Seleusan, Diana Cenariu, Diana Gulei, David Kegyes, Adrian Bogdan Tigu, Sadia Riaz, Mihnea Zdrenghea, Ciprian Tomuleasa

10.1016/j.critrevonc.2026.105651
View Publication

When Is 4Gy Enough? Defining Dose Sufficiency and Durable Control in Indolent B-Cell Lymphoma

Yun Yang, Hong Zhu, Jun Liu, Bichun Xu, Bing Xiu, Meihua Wang, Judong Luo

10.1016/j.critrevonc.2026.105649
View Publication

Rewiring the Tumor–Immune Ecosystem: Extracellular Vesicles in the Next Era of Cancer Immunotherapy

Ahmed Reda Bahr, Youssef Basem, Abdelrahman Alaa, Maria Tamer, Amira Basem, Mariam Hossam El-deen, Esraa M. Halawa

10.1016/j.critrevonc.2026.105642
View Publication

Perioperative immune-based treatment for cisplatin-eligible muscle-invasive bladder cancer: a meta-analysis of randomized controlled trials.

Veronica Mollica, Matteo Rosellini, Patrizia Giannatempo, Shilpa Gupta, Enrique Grande, Alessandro Rizzo, Costantino Ricci, Pietro Piazza, Roberto Contieri, Arrigo Cattabriga, Riccardo Schiavina, Matteo Santoni, Francesco Massari

10.1016/j.critrevonc.2026.105648
View Publication

Frequently asked questions

How long does it take to publish?

7 days submission to first decision; 27 days submission to decision after review; 69 days submission to acceptance; 2 days from acceptance to first online publication.

Reformat to Critical Reviews in Oncology/Hematology using Livewrite Premium

What are the publication costs?

Open Access APC: USD 4,180 (excluding taxes); subscription: no publication fee charged to authors.

Reformat to Critical Reviews in Oncology/Hematology using Livewrite Premium

Research Topics

Lung Cancer Treatments and Mutations Diverse Scientific and Economic Studies Cancer Immunotherapy and Biomarkers Human auditory perception and evaluation Educational Robotics and Engineering Colorectal Cancer Treatments and Studies Cancer Genomics and Diagnostics Lymphoma Diagnosis and Treatment Cancer Treatment and Pharmacology Lung Cancer Research Studies Breast Cancer Treatment Studies Immunotherapy and Immune Responses HER2/EGFR in Cancer Research Frailty in Older Adults Prostate Cancer Treatment and Research CAR-T cell therapy research Chronic Lymphocytic Leukemia Research Cancer survivorship and care Acute Myeloid Leukemia Research Pancreatic and Hepatic Oncology Research Ovarian cancer diagnosis and treatment Glioma Diagnosis and Treatment Gastric Cancer Management and Outcomes Cancer Cells and Metastasis Head and Neck Cancer Studies

Related Journals

NJ
NFS Journal Elsevier BV
TL
The Lancet Rheumatology Elsevier BV
ID
Infectious Diseases Now Elsevier BV
TO
The Oncologist AlphaMed Press
AP
Acta Pharmaceutica Sinica B Elsevier BV
BA
Biomaterials Advances Elsevier BV